IFM Investors Pty Ltd Has $1.68 Million Stake in Agilent Technologies Inc (NYSE:A)
IFM Investors Pty Ltd grew its position in shares of Agilent Technologies Inc (NYSE:A) by 13.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,515 shares of the medical research company’s stock after buying an additional 2,649 shares during the quarter. IFM Investors Pty Ltd’s holdings in Agilent Technologies were worth $1,681,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in A. Lake Point Wealth Management acquired a new stake in Agilent Technologies in the 4th quarter worth approximately $30,000. Destination Wealth Management lifted its holdings in Agilent Technologies by 100.0% in the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock worth $32,000 after purchasing an additional 200 shares during the last quarter. Financial Gravity Wealth Inc. acquired a new stake in Agilent Technologies in the 1st quarter worth approximately $52,000. Knuff & Co LLC lifted its holdings in Agilent Technologies by 203.3% in the 1st quarter. Knuff & Co LLC now owns 910 shares of the medical research company’s stock worth $73,000 after purchasing an additional 610 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in Agilent Technologies by 36.3% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,193 shares of the medical research company’s stock worth $96,000 after purchasing an additional 318 shares during the last quarter.
Several equities research analysts recently weighed in on the company. Wolfe Research assumed coverage on Waters in a report on Thursday, May 30th. They issued an “underperform” rating for the company. Zacks Investment Research upgraded Golub Capital BDC from a “hold” rating to a “buy” rating and set a $20.00 target price for the company in a report on Tuesday, July 16th. Bank of America upgraded First Horizon National from an “underperform” rating to a “neutral” rating and set a $16.00 target price for the company in a report on Tuesday, July 16th. ValuEngine upgraded Valmont Industries from a “sell” rating to a “hold” rating in a report on Friday, July 12th. Finally, Deutsche Bank upped their price target on Alphabet from $1,300.00 to $1,400.00 and gave the stock a “buy” rating in a report on Wednesday, May 15th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $83.92.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm earned $0.65 earnings per share. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, equities analysts expect that Agilent Technologies Inc will post 3.05 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd were issued a dividend of $0.164 per share. The ex-dividend date of this dividend was Monday, July 1st. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.94%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Article: Different Types of Derivatives
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.